Keyphrases
Carbohydrate Antigen 19-9 (CA19-9)
33%
Chemoradiation
100%
Chemotherapy
33%
Locally Advanced Cancer
33%
Long-term Survival
33%
Multivariate Analysis
33%
National Cancer Database
33%
Neoadjuvant Chemoradiotherapy (nCRT)
100%
Nine-level
33%
Optimal Time Interval
33%
Pancreatic Adenocarcinoma
100%
Pancreaticoduodenectomy
100%
Patient Needs
33%
Patient Selection
33%
Positive Surgical Margin
33%
Progressive Disease
33%
Prolonged Survival
33%
Radiation Dose
33%
Selection Criteria
33%
Short-term Outcomes
100%
Surgical Resection
100%
Survival Benefit
33%
Medicine and Dentistry
Chemoradiotherapy
100%
Clinical Stage
33%
Long Term Survival
16%
Malignant Neoplasm
16%
Multivariate Analysis
16%
Neoplasm
16%
Pancreas Adenocarcinoma
50%
Pancreaticoduodenectomy
100%
Patient Selection
16%
Progressive Disease
16%
Stage 3 Cancer
16%
Surgery
50%
Surgical Margin
16%